Seuraa
Rakesh Jain
Rakesh Jain
Massachusetts General Hospital, Harvard Medical School, Carnegie Mellon, Columbia, Delaware
Vahvistettu sähköpostiosoite verkkotunnuksessa steele.mgh.harvard.edu - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Angiogenesis in cancer and other diseases
P Carmeliet, RK Jain
nature 407 (6801), 249-257, 2000
118862000
Photodynamic therapy for cancer
DE Dolmans, D Fukumura, RK Jain
Nature reviews cancer 3 (5), 380-387, 2003
73232003
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy
RK Jain
Science 307 (5706), 58-62, 2005
64272005
Molecular mechanisms and clinical applications of angiogenesis
P Carmeliet, RK Jain
Nature 473 (7347), 298-307, 2011
60422011
Understanding the tumor immune microenvironment (TIME) for effective therapy
M Binnewies, EW Roberts, K Kersten, V Chan, DF Fearon, M Merad, ...
Nature medicine 24 (5), 541-550, 2018
41792018
Delivering nanomedicine to solid tumors
RK Jain, T Stylianopoulos
Nature reviews Clinical oncology 7 (11), 653-664, 2010
34752010
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
P Carmeliet, Y Dor, JM Herbert, D Fukumura, K Brusselmans, ...
Nature 394 (6692), 485-490, 1998
33851998
Molecular regulation of vessel maturation
RK Jain
Nature medicine 9 (6), 685-693, 2003
33662003
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment
SK Hobbs, WL Monsky, F Yuan, WG Roberts, L Griffith, VP Torchilin, ...
Proceedings of the National Academy of Sciences 95 (8), 4607-4612, 1998
29941998
Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy
RK Jain
Nature medicine 7 (9), 987-989, 2001
26762001
A framework for advancing our understanding of cancer-associated fibroblasts
E Sahai, I Astsaturov, E Cukierman, DG DeNardo, M Egeblad, RM Evans, ...
Nature Reviews Cancer 20 (3), 174-186, 2020
25912020
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett, Y Boucher, E Di Tomaso, DG Duda, LL Munn, RT Tong, ...
Nature medicine 10 (2), 145-147, 2004
24882004
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size
F Yuan, M Dellian, D Fukumura, M Leunig, DA Berk, VP Torchilin, RK Jain
Cancer research 55 (17), 3752-3756, 1995
22951995
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
TT Batchelor, AG Sorensen, E di Tomaso, WT Zhang, DG Duda, ...
Cancer cell 11 (1), 83-95, 2007
20882007
Openings between defective endothelial cells explain tumor vessel leakiness
H Hashizume, P Baluk, S Morikawa, JW McLean, G Thurston, S Roberge, ...
The American journal of pathology 156 (4), 1363-1380, 2000
20692000
Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
G Helmlinger, F Yuan, M Dellian, RK Jain
Nature medicine 3 (2), 177-182, 1997
20061997
Determinants of tumor blood flow: a review
RK Jain
Cancer research 48 (10), 2641-2658, 1988
19031988
Transport of molecules in the tumor interstitium: a review
RK Jain
Cancer research 47 (12), 3039-3051, 1987
19011987
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
18602020
Barriers to drug delivery in solid tumors
RK Jain
Scientific American 271 (1), 58-65, 1994
18591994
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20